What VieCure does
VieCure builds Halo Intelligence, an oncology platform for community cancer practices that combines an AI inference engine, a codified clinical knowledge base and a purpose-built oncology electronic medical record. The company says the platform delivers real-time clinical decision support by combining patient data with evidence-based knowledge and digital workflows at the point of care. It also includes a practice operating system, third-party integrations, data and analytics, tele-oncology, and mobile apps for physicians and patients. VieCure says it manages care for about 30,000 patients, and in 2025 it announced that NCCN guideline content had been integrated into the platform.
VieCure is a healthcare tool on Falcoscan. Oncology EMR and clinical decision support platform for community cancer practices. Falcoscan rates VieCure with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. VieCure is founded in 2015, currently at Series_c stage. Pricing: Paid.